President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Iran Military Readiness Intensifies After Meeting With Mojtaba Khamenei
Netanyahu Signals Plan to End Reliance on U.S. Military Aid Within 10 Years
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
The four types of dementia most people don’t know exist
Trump Weighs Renewed Iran Military Action Amid Hormuz Tensions
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Israeli Strikes in Gaza Kill Three Amid Fragile Ceasefire Tensions
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Keir Starmer Faces Mounting Pressure as Labour MPs Demand Leadership Change
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher
US Sanctions Target Iran Oil Network Supplying China Ahead of Trump-Xi Talks 



